Pure Global Cannabis Inc. Stock Other OTC
Equities
PRCNF
CA74625A1075
Pharmaceuticals
Financials (USD)
Sales 2017 | - | Sales 2018 | - | Capitalization | 24.16M |
---|---|---|---|---|---|
Net income 2017 | - | Net income 2018 | -23M | EV / Sales 2017 * | - |
Net Debt 2017 | 211K | Net Debt 2018 | 4.49M | EV / Sales 2018 | - |
P/E ratio 2017 * |
-
| P/E ratio 2018 |
-0.72
x | Employees | - |
Yield 2017 * |
-
| Yield 2018 |
-
| Free-Float | 83.64% |
Managers | Title | Age | Since |
---|---|---|---|
Vik Chopra
CTO | Chief Tech/Sci/R&D Officer | - | - |
Sanjeev Goel
CTO | Chief Tech/Sci/R&D Officer | - | - |
Michael Lavergne
PRN | Corporate Officer/Principal | - | 18-07-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Jane E. Pagel
BRD | Director/Board Member | - | 18-06-30 |
1st Jan change | Capi. | |
---|---|---|
+42.07% | 6.28B | |
-21.20% | 4.25B | |
+5.38% | 3.36B | |
-16.98% | 2.96B | |
-5.82% | 2.45B | |
+45.47% | 1.97B | |
-12.67% | 1.61B | |
-3.91% | 1.6B | |
+44.56% | 1.51B |